Barre Exercise in Parkinson's

Parkinson Disease Clinical Trial

Official title:

Barre Exercise for People With Parkinson Disease

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06203990
• Other study ID #: 202312097
• Status: Active, not recruiting
• Phase: Phase 1
• Start date: January 2, 2024
• Est. completion date: May 20, 2024

Study information

• Verified date: March 2024
• Source: Washington University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study asks if a barre exercise program is a feasible and acceptable form of exercise for individuals with Parkinson disease. The study will also evaluate barre's potential effects on motor outcomes, including balance, strength, and functional mobility.

Description:

The primary objectives of this study are to: 1) evaluate the feasibility and acceptability of a barre exercise intervention and 2) gather preliminary data regarding the effect of a barre exercise intervention on balance, strength, functional mobility and quality of life in individuals with mild to moderate Parkinson disease (PD). Individuals with PD (N=15) will be recruited to participate in a pilot barre exercise class led by a certified barre instructor. The intervention will include 24, 45-50 minute group classes (twice weekly for 12 weeks, excluding holidays). Pre- and post-intervention data collection will include assessments of balance, lower extremity strength, and functional mobility.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 15
• Est. completion date: May 20, 2024
• Est. primary completion date: May 20, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• diagnosed by a neurologist with idiopathic Parkinson disease
• at least 18 years of age
• a score on the Hoehn & Yahr (H&Y) scale between I-III to indicate mild to moderate disease severity
• able to provide informed consent
• able to walk for 10 continuous minutes without assistance from another person
• stable medication regimen for at least one month prior to enrollment

Exclusion Criteria:

• any neurological condition other than PD
• history of orthopedic or other medical conditions that limit the ability to safely participate in the intervention or
• language, visual, or hearing barriers to participation
• evidence of dementia (Montreal Cognitive Assessment < 24) to ensure understanding of the intervention class instructions

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Behavioral:
• Barre exercise
Group barre exercise class

Locations

Country	Name	City	State
United States	Washington University School of Medicine	Saint Louis	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Attendance	Percent of clases attended	12 weeks
Primary	Study Completion	Percent of participants who finish full study	12 weeks
Secondary	Balance	Change in score on Mini-BESTest	12 weeks
Secondary	Functional Strength	Change in time to complete five sit to stand movements	12 weeks
Secondary	Gait	Change in gait speed	12 weeks